HEALTH ALERT! If you have any of the following, please call our office before coming in for your appointment: Fever AND cough; Fever OR cough and recent travel (domestic or international to any destination); Recent international travel to areas impacted by the Coronavirus (2019-nCoV) within the last 14 days; OR close contact with someone who has traveled outside the US or been exposed to the Coronavirus.

We are also limiting the numbers of caregivers that may attend visits at our Practice. Please click the More info link below to get detailed information on recent changes made to ensure the safety of our patients and employees. More Info

For any additional information, please be encouraged to refer to the CDC guidelines and the Virginia Department of Health for up to date information, and to answer further questions that you may have.

https://www.cdc.gov/coronavirus/2019-ncov/index.html
https://www.vdh.virginia.gov/coronavirus

Treatments & Services

Clinical Trials

Advancing Cancer Care through Clinical Trials

Today, clinical trial research is no longer conducted exclusively at large university cancer centers or major metropolitan hospitals.  Shenandoah Oncology has embraced clinical trial research as a critical component of community-based care for patients with cancer or blood disorders.  

At Shenandoah Oncology we are dedicated to finding new and better ways to treat cancer through research and clinical trials.  We have access to clinical trials through our affiliation with US Oncology Research and as a clinical research affiliate of Virginia Commonwealth University.  

Participating in these clinical trials also allows us to provide valuable access to new investigational cancer agents to patients right here in their community.  Our patients are able to access state-of-the-art investigational therapies, while their own physician directs and closely monitors their care.  Patients are able to remain at home near family and loved ones.

Furthermore, our research network is also looking toward the future by developing initiatives in “personalized” or “individualized” medicine.  These types of clinical trials offer the potential to recommend drug treatment based on the genetic makeup of the patient's tumor.

50,000 Patients, One Goal

As a member of the US Oncology Research Network, Shenandoah Oncology is pleased to provide local patients access to cutting-edge and innovative clinical trials in a comfortable and convenient setting. US Oncology Research, supported by McKesson Specialty Health, recently announced that it has surpassed the 50,000 milestone for number of patients enrolled in its clinical trials program.   One of the largest and most reputable community-based research networks in the world, US Oncology Research specializes in Phase I–IV oncology clinical trials and has participated in over 1,200 investigator-initiated and sponsor-initiated trials since its inception, and was pivotally involved in the development and approval of over 40 innovative cancer treatments in the last decade.

In addition, Shenandoah Oncology is a proud clinical research affiliate of Virginia Commonwealth University's Massey Cancer Center, and this program allows us to offer additional innovative therapies and clinical trials to our patients to help advance the science of cancer care while offering the best possible treatments and improved patient outcomes.  If you would like more information, you may speak to your physician or our research department about the open clinical trials.

Learn More